PLSE

Pulse Biosciences (PLSE)

About Pulse Biosciences (PLSE)

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Details

Daily high

$15.38

Daily low

$14.33

Price at open

$14.40

52 Week High

$25.00

52 Week Low

$12.56

Market cap

1.0B

Dividend yield

0.00%

Volume

279,385

Avg. volume

185,260

P/E ratio

-13.44

Pulse Biosciences News